Arlington Trust Co LLC Purchases 474 Shares of Zoetis Inc. (NYSE:ZTS)

Arlington Trust Co LLC lifted its holdings in Zoetis Inc. (NYSE:ZTS) by 55.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,327 shares of the company’s stock after purchasing an additional 474 shares during the quarter. Arlington Trust Co LLC’s holdings in Zoetis were worth $216,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. AMF Tjanstepension AB grew its position in Zoetis by 23.4% in the third quarter. AMF Tjanstepension AB now owns 105,376 shares of the company’s stock worth $20,594,000 after acquiring an additional 20,001 shares in the last quarter. CWM LLC boosted its holdings in shares of Zoetis by 1.8% in the 3rd quarter. CWM LLC now owns 19,330 shares of the company’s stock worth $3,777,000 after purchasing an additional 339 shares during the period. LVW Advisors LLC increased its position in shares of Zoetis by 11.8% during the 3rd quarter. LVW Advisors LLC now owns 1,470 shares of the company’s stock valued at $287,000 after purchasing an additional 155 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in Zoetis by 307.5% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,930 shares of the company’s stock valued at $572,000 after buying an additional 2,211 shares during the period. Finally, Valeo Financial Advisors LLC lifted its position in Zoetis by 1.1% in the third quarter. Valeo Financial Advisors LLC now owns 8,028 shares of the company’s stock worth $1,568,000 after buying an additional 91 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on ZTS shares. Stifel Nicolaus cut their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Leerink Partners started coverage on shares of Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective on the stock. Morgan Stanley dropped their target price on Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a research report on Wednesday, January 29th. UBS Group initiated coverage on Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. Finally, Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. One analyst has rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Zoetis has an average rating of “Buy” and an average target price of $215.00.

Zoetis Stock Down 1.6 %

Shares of Zoetis stock opened at $171.37 on Monday. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.53. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The stock has a market cap of $77.32 billion, a price-to-earnings ratio of 32.21, a PEG ratio of 2.77 and a beta of 0.90. The firm’s 50-day moving average is $169.26 and its two-hundred day moving average is $179.22.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis’s dividend payout ratio (DPR) is 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.